Drug Detail

Drug Name Relatlimab
Trade Name
Synonyms BMS-986016
Drug Descriptions

Relatlimab (BMS-986016) is a monoclonal antibody that targets LAG3 and inhibits binding of MHC II molecules to increase cytokine production by T-cells and prevent tumor growth (Journal of Clinical Oncology 35, no. 15_suppl (May 20 2017) 9520-9520).

DrugClasses Immune Checkpoint Inhibitor 99 LAG3 Antibody 10

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
BMS-986205 + Nivolumab + Relatlimab BMS-986205 Nivolumab Relatlimab 0 1
Capecitabine + Nivolumab + Oxaliplatin + Relatlimab Capecitabine Nivolumab Oxaliplatin Relatlimab 0 1
Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin + Relatlimab Fluorouracil Leucovorin Nivolumab Oxaliplatin Relatlimab 0 1
Ipilimumab + Nivolumab + Relatlimab Ipilimumab Nivolumab Relatlimab 0 1
Ipilimumab + Relatlimab Ipilimumab Relatlimab 0 1
Nivolumab + Paclitaxel + Relatlimab Nivolumab Paclitaxel Relatlimab 0 1
Nivolumab + Relatlimab Nivolumab Relatlimab 0 15
Nivolumab + Relatlimab + TS-1 Nivolumab Relatlimab TS-1 0 1
Relatlimab Relatlimab 0 3
Relatlimab + Urelumab Relatlimab Urelumab 1 0


Additional content available in CKB BOOST